The Food and Drug Administration (FDA) has granted Fast Track designation to RDD-0315, a novel topical gel for the treatment of fecal incontinence in spinal cord injury patients.
Drug News
The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for golodirsen (SRP-4053; Sarepta), a treatment designed for patients with Duchenne muscular dystrophy (DMD) who have genetic mutations that are amenable to exon 53 skipping.
Combo tx linked to significant reductions in LDL, total cholesterol, triglycerides versus rosuvastatin
Florida health officials say they’re investigating a second possible case of locally transmitted Zika infection.
The financial outlook for primary care practices is improving, but not all practices are experiencing the same improvements, according to an article published in Medical Economics.
Long-term use of statins does not appear to reduce the risk of colorectal cancer (CRC), but a patient’s cholesterol levels might affect risk, according to a study published online in PLOS Medicine.
Preventive mastectomy that preserves the nipple and surrounding skin may be as effective in preventing breast cancer in high-risk women as more invasive surgeries, according to a study presented at the annual meeting of the American Society of Breast Surgeons (ASBS).
reatment with the selective noradrenalin-reuptake-inhibitor atomoxetine is not associated with increased suicide risk compared with stimulant use in children and adolescents, according to a study published online in Pediatrics.
For patients undergoing transcatheter mitral valve repair (TMVR), the six-minute walk test (6MWT) is independently associated with mortality, according to a research letter published in the Journal of the American College of Cardiology.
Detection of concerning symptoms after radical cystectomy can be improved by optimizing the timing and number of outpatient encounters, according to a study published in the May issue of The Journal of Urology.
- Loading...
Want to read more?
Please login or register first to view this content.
